45th Annual Meeting of the American-Society-of-Clinical-Oncology Conference

Scholarly Activity

related documents

A phase II study evaluating the safety and efficacy of patupilone in patients with platinum refractory/resistant ovarian, primary fallopian, or peritoneal cancer Conferences
A phase II study of Halichondrin B analog eribulin mesylate (E7389) as second-line therapy for patients with advanced pancreatic cancer Conferences
A phase II study of patupilone in patients (pts) with metastatic castration-resistant prostate cancer (CRPC) who have progressed after docetaxel Conferences
A phase II study of single agent abraxane as second-line therapy in patients with advanced urothelial carcinoma Conferences
A phase II study of sunitinib in recurrent or metastatic endometrial carcinoma: A trial of the PMH Phase II Consortium Conferences
A phase II trial of voreloxin in women with platinum-resistant ovarian cancer Conferences
A randomized phase II trial of a new anticoagulant, apixaban, in metastatic cancer Conferences
Case report of a 27-year-old male with DCIS Conferences
Comparison of randomized phase II studies (RP2s) and subsequent randomized controlled studies (RCTs) using identical systemic therapies Conferences
Cost-effectiveness of cetuximab for the first-line treatment of squamous cell carcinoma of the head and neck (SCCHN) in Canada Conferences
Dalteparin low molecular weight heparin (LMWH) in ovarian cancer: A phase II randomized study Conferences
Differences in uptake of postoperative adjuvant chemotherapy for lung cancer: Results from the Project for an Ontario Women's Health Evidence-Based Report Card (POWER) study Conferences
Economic guidelines for oncology products: Adaptation of the Canadian Agency for Drugs and Technologies in Health (CADTH) technology assessment guidance document Conferences
Effect of geographic distance from a cancer centre on choice of systemic therapy in metastatic colorectal cancer Conferences
Hypertension (HTN) in National Cancer Institute of Canada Clinical Trials Group study BR.24: A randomized, double-blind phase II trial of carboplatin (C) and paclitaxel (P) with either daily oral cediranib (CED), an inhibitor of vascular endothelial growth factor receptors, or placebo, in patients with advanced non-small cell lung cancer Conferences
Impact of positron emission tomography (PET) in stage III non-small cell lung cancer (NSCLC): A prospective randomized trial (PET START) Conferences
Importance of stratification when measuring quality of care: Results from the Project for an Ontario Women's Health Evidence-Based Report Card (POWER) study Conferences
Integration between primary care providers and the cancer system: Gaps and opportunities Conferences
Interim analysis of a phase II trial of 5-azacitidine (5AC) and entinostat (SNDX-275) in relapsed advanced lung cancer (NSCLC) Conferences
Mature results of a randomized phase II study of OGX-011 in combination with docetaxel/prednisone versus docetaxel/prednisone in patients with metastatic castration-resistant prostate cancer Conferences
OGX-427, a 2 ' methoxyethyl antisense oligonucleotide (ASO), against HSP27: Results of a first-in-human trial Conferences
PET-CT compared to invasive mediastinal staging in non-small cell lung cancer (NSCLC) Conferences
Phase I dose escalation trial of sorafenib as a single agent for adults with relapsed and refractory acute leukemias Conferences
Phase I study of intravenous decitabine in combination with oral vorinostat in patients with advanced solid tumors and non-Hodgkin's lymphomas (NHL) Conferences
Phase II study of AVR118 in the management of cancer related anorexia/cachexia Conferences
Phase II study of MKC-1 in patients with metastatic or resistant epithelial ovarian cancer or advanced endometrial cancer Conferences
Phase Ib dose finding trial of intravenous panobinostat with docetaxel in patients with castration-resistant prostate cancer (CRPC) Conferences
Predictors of recurrent thrombosis and anticoagulant-related bleeding in patients with cancer Conferences
Primary tumor and patient characteristics in breast cancer as predictors of adjuvant chemotherapy regimen: A regression model Conferences
Randomized Phase II Study of Docetaxel and Prednisone With or Without OGX-011 in Patients With Metastatic Castration-Resistant Prostate Cancer Conferences
The McGill Cancer Nutrition and Rehabilitation Program Conferences
The management of dysphagia in esophageal cancer patients undergoing neoadjuvant chemotherapy: Is invasive tube feeding required? Conferences
Treatment and outcome of patients with brain metastases from non-small cell lung cancer (NSCLC) Conferences
Trends in the application of dynamic allocation methods in multiarm cancer clinical trials Conferences
Two-years biochemical failure-free survival following high intensity focused ultrasound (HIFU) for localized prostate cancer: Prospective single center study of 196 patients Conferences
Willingness of breast cancer survivors to participate in a randomized controlled trial (RCT) of digital mammography with or without magnetic resonance imaging (MRI) as breast cancer (BC) surveillance: A feasiblity study Conferences